Skip to content
2000
  • ISSN: 1568-0142
  • E-ISSN: 1875-6131

Abstract

Interferon g (IFN-γ) is a regulatory cytokine with a broad spectrum of biologic activities and considerable clinical importance. It is considered to be a master regulator of the immune system. Many human diseases, including infections, cancer and autoimmunity, are associated with aberrant production of IFN-γ. Detection and regulation of IFN-γ production is an important clinical objective. Today, levels of IFN-γ in body fluids and tissues can be reproducibly measured by a variety of assays, including single-cell assays, that are discussed below. Strategies for inhibition of IFN-γ secretion depend on immunologic, pharmacologic or genetic interventions. Increasingly, molecular approaches based on inhibition of IFN-γ signaling pathways are considered for down-regulation of excessive IFN-γ production in various pathologic conditions.

Loading

Article metrics loading...

/content/journals/cmcaiaa/10.2174/1568014053507096
2005-04-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/cmcaiaa/10.2174/1568014053507096
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test